Tag Archives: NGS

Early Access Program Launch for New Clinical Lab Solution

At the annual AMP meeting this week, we announced that we’ve started to enroll more clinical labs into the Early Access Program for our new clinical interpretation and reporting solution for molecular pathologists and medical geneticists. It’s an exciting milestone … Read More

Posted in Product Announcements | Tagged , ,

Variant Analysis Hits the Road! Join Us for the Ion Tour of Europe

For the next month, we will be participating in Ion Tour 2013, the traveling Ion Torrent™ user group meetings taking place in Europe from now till the start of October. Stops include Vienna, Madrid, Birmingham, Budapest, and more. We are … Read More

Posted in Events, Ingenuity Variant Analysis | Tagged , , , , ,

Still Time to Submit a Grant Application…It’s Easy!

Ingenuity Systems Fall Grant program is quickly coming to the submission deadline – Friday, August 23rd! If your work involves cancer, infectious or rare disease, drug response, or genome interpretation, this may be the perfect opportunity for you. We adjusted … Read More

Posted in Ingenuity Variant Analysis, IPA | Tagged , , , , , , , ,

Survey Says…You Like Us!

We recently hired an independent survey company to ask Ingenuity customers about their experiences with our Variant Analysis product, and we’re delighted by the results. Facilitated by TechValidate, the data gathered presents the real-world experiences of verified users of our … Read More

Posted in Customer Success Stories, Ingenuity Variant Analysis, Surveys | Tagged , , , , , , ,

At the heart of the sequencing debate…lies Ingenuity Variant Analysis

Whether you use whole genome or whole exome technologies, the next-generation sequencing industry continues to face the difficult task of relating NGS data back to affected biology.   Ingenuity Variant Analysis solves this problem by allowing researchers to identify causal … Read More

Posted in Ingenuity Partners, Ingenuity Variant Analysis, News, NGS | Tagged , , , , , , , , , , ,

Free whitepaper: Integrated RNA-Seq Data Analysis Pipeline – Generating Evidence-Backed Hypotheses in Silico

Download the free white paper from Ingenuity to see how IPA and CLC bio can help with in silico analysis of RNA-Seq data to identify patient-specific prostate cancer mechanisms, potential biomarkers, and to generate evidence-backed hypotheses. You can also register … Read More

Posted in Biomarkers, Customer Resources, Hypothesis Generation, Ingenuity Partners, IPA Training, Neuroscience, NGS, Oncology, RNA-Seq | Tagged , , , , , , , , ,